Skip to main content
. Author manuscript; available in PMC: 2020 Dec 4.
Published in final edited form as: Circ Cardiovasc Qual Outcomes. 2019 Nov 12;12(11):e000057. doi: 10.1161/HCQ.0000000000000057
Reviewer Representation Employment Consultant Speakers Bureau Ownership/Partnership/Principal Personal Research Institutional, Organizational, or Other Financial Benefit Expert Witness Salary
Biykem Bozkurt Official TFPM Lead; TFDS Content Reviewer Baylor College of Medicine—Mary and Gordon Cain Chair Professor of Medicine and Director, Winters Center for Heart Failure Research; Michael E. DeBakey VA Medical Center, Cardiology—Chief, Cardiology Section
  • Bayer

  • Bristol-Myers Squibb

  • Lantheus Medical Imaging, Inc

  • LivaNova USA

  • Respicardia

  • scPharmaceuticals

None None
  • LivaNova USA (DSMB)

  • Abbott

None None
Nicole L. Lohr Official ACC Medical College of Wisconsin—Assistant Professor None None None None None None
Andrea L. Price Official ACC Indiana University Health—Director, Quality Databases None None None None
  • ACC Accreditation Foundation Board*

None None
Brent Egan Official AHA Medical University of South Carolina, Charleston (MUSC)—Professor of Medicine and Pharmacology
  • Medtronic

  • Emcure

  • Merck KGaA

None None
  • UpToDate

None None
John M. Flack Official AHA Southern Illinois University School of Medicine, Internal Medicine—Professor, Chair, and Chief of Hypertension Specialty Services None None None
  • National Institutes of Health (DSMB)

None None
Sandra J. Taler Official AHA Mayo Clinic—Professor of Medicine None None None None None None None
Michael Rakotz Official AMA American Medical Association—Vice President, Health Outcomes None None None None None None
Cheryl Dennison-Himmelfarb Official PCNA Johns Hopkins School of Nursing—Associate Dean for Research, Sarah E. Allison Endowed Professor, and Deputy Director, Institute for Clinical Translational Research None None None
  • Helene Fuld Health Trust*

  • NIH*

None
  • Johns Hopkins University*

Nathalie De Michelis Content ACC University of California, Irvine—Cardiovascular Program Manager None None None None None None None
Eugene Yang Content ACC University of Washington School of Medicine—Medical Director and Clinical Associate Professor of Medicine, Division of Cardiology, Carl and Renee Behnke Endowed Professorship for Asian Health
  • Amgen*

  • RubiconMD*

None None None
  • Amgen*

  • Third Party, Firefighter who developed an arrhythmia at work, 2017*

None
Marjorie L. King Content ACC/AHA Helen Hayes Hospital—Chief Medical Officer, Internal Medicine (Cardiology) and Director, Cardiopulmonary, Rehabilitation
  • Island Peer Review Organization*

None None None None None None
Raj Padwal Content AMA University of Alberta—Professor of Medicine and Director, Hypertension Dyslipidemia Clinic None None None None None None
Nancy Houston-Miller Content PCNA The Lifecare Company—Associate Director
  • Moving Analytics*

None None None None None None

This table represents all relationships of reviewers with industry and other entities that were reported at the time of peer review, including those not deemed to be relevant to this document, at the time this document was under review. The table does not necessarily reflect relationships with industry at the time of publication. A person is deemed to have a significant interest in a business if the interest represents ownership of ≥5% of the voting stock or share of the business entity, or ownership of ≥$5 000 of the fair market value of the business entity; or if funds received by the person from the business entity exceed 5% of the person’s gross income for the previous year. Relationships that exist with no financial benefit are also included for the purpose of transparency. Relationships in this table are modest unless otherwise noted. Names are listed in alphabetical order within each category of review. Please refer to http://www.acc.org/guidelines/about-guidelines-and-clinical-documents/relationships-with-industry-policy for definitions of disclosure categories or additional information about the ACC/AHA Disclosure Policy for Writing Committees.

*

Significant relationship.

No financial benefit.

This disclosure was entered under the Clinical Trial Enroller category in the ACC’s disclosure system. To appear in this category, the reviewer acknowledges that there is no direct or institutional relationship with the trial sponsor as defined in the ACCF or ACC/AHA Disclosure Policy for Writing Committees.

ACC indicates American College of Cardiology; AHA, American Heart Association; AMA, American Medical Association; DSMB, Data Safety and Monitoring Board; HBP, high blood pressure; NIH, National Institutes of Health; PCNA, Preventive Cardiovascular Nurses Association; TFDS, Task Force for Data Standards; and TFPM, Task Force on Performance Measures.